309 related articles for article (PubMed ID: 20449688)
21. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
Apostolakis EM; Riherd DN; O'Malley BW
Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
[TBL] [Abstract][Full Text] [Related]
22. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
23. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotective role of the VIP signaling system.
Dvoráková MC
Timely Top Med Cardiovasc Dis; 2005 Oct; 9():E33. PubMed ID: 16341283
[TBL] [Abstract][Full Text] [Related]
25. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
26. Effects of CYP-Induced Cystitis on Growth Factors and Associated Receptor Expression in Micturition Pathways in Mice with Chronic Overexpression of NGF in Urothelium.
Girard BM; Malley S; May V; Vizzard MA
J Mol Neurosci; 2016 Aug; 59(4):531-43. PubMed ID: 27259880
[TBL] [Abstract][Full Text] [Related]
27. PAC1- and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice.
Hannibal J; Georg B; Fahrenkrug J
PLoS One; 2017; 12(11):e0188166. PubMed ID: 29155851
[TBL] [Abstract][Full Text] [Related]
28. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
[TBL] [Abstract][Full Text] [Related]
29. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors are present and biochemically active in the central nervous system of the pond snail Lymnaea stagnalis.
Pirger Z; Laszlo Z; Hiripi L; Hernadi L; Toth G; Lubics A; Reglodi D; Kemenes G; Mark L
J Mol Neurosci; 2010 Nov; 42(3):464-71. PubMed ID: 20396976
[TBL] [Abstract][Full Text] [Related]
30. Increased TRPV4 expression in urinary bladder and lumbosacral dorsal root ganglia in mice with chronic overexpression of NGF in urothelium.
Girard BM; Merrill L; Malley S; Vizzard MA
J Mol Neurosci; 2013 Oct; 51(2):602-14. PubMed ID: 23690258
[TBL] [Abstract][Full Text] [Related]
31. Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors.
Langer I; Latek D
Front Endocrinol (Lausanne); 2021; 12():711906. PubMed ID: 34867774
[TBL] [Abstract][Full Text] [Related]
32. PACAP and PAC1 receptor in brain development and behavior.
Shen S; Gehlert DR; Collier DA
Neuropeptides; 2013 Dec; 47(6):421-30. PubMed ID: 24220567
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
Schulz S; Röcken C; Mawrin C; Weise W; Höllt V; Schulz S
Clin Cancer Res; 2004 Dec; 10(24):8235-42. PubMed ID: 15623599
[TBL] [Abstract][Full Text] [Related]
34. Expression of vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets.
Vuckovic A; Rondelet B; Brion JP; Naeije R
Pediatr Res; 2009 Oct; 66(4):395-9. PubMed ID: 19581838
[TBL] [Abstract][Full Text] [Related]
35. Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats.
Han X; Ran Y; Su M; Liu Y; Tang W; Dong Z; Yu S
Mol Pain; 2017; 13():1744806917720361. PubMed ID: 28776455
[TBL] [Abstract][Full Text] [Related]
36. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotective role of the VIP signaling system.
Dvoráková MC
Drug News Perspect; 2005; 18(6):387-91. PubMed ID: 16247516
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional and translational plasticity in rodent urinary bladder TRP channels with urinary bladder inflammation, bladder dysfunction, or postnatal maturation.
Merrill L; Girard BM; May V; Vizzard MA
J Mol Neurosci; 2012 Nov; 48(3):744-56. PubMed ID: 22865090
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.
Schnegelsberg B; Sun TT; Cain G; Bhattacharya A; Nunn PA; Ford AP; Vizzard MA; Cockayne DA
Am J Physiol Regul Integr Comp Physiol; 2010 Mar; 298(3):R534-47. PubMed ID: 20032263
[TBL] [Abstract][Full Text] [Related]
40. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
